Q32 Bio Stock Performance
| QTTB Stock | 2.19 0.13 5.60% |
Q32 Bio holds a performance score of 4 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of 1.68, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Q32 Bio will likely underperform. Use Q32 Bio value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to analyze future returns on Q32 Bio.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Q32 Bio are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Q32 Bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (5.39) | Five Day Return (17.48) | Year To Date Return (36.38) | Ten Year Return (99.35) | All Time Return (99.35) |
Last Split Factor 1:18 | Last Split Date 2024-03-26 |
1 | Q32 Bio Announces FDA Fast Track Designation Granted to Bempikibart for the Treatment of Alopecia Areata | 04/30/2025 |
2 | Acquisition by Tzianabos Arthur of 12767 shares of Q32 Bio at 2.54 subject to Rule 16b-3 | 05/05/2025 |
3 | Q32 Bio GAAP EPS of -0.90 | 05/08/2025 |
4 | Q32 Bio receives Nasdaq noncompliance notice - Investing.com | 05/23/2025 |
5 | Acquisition by Manke Isaac of 12767 shares of Q32 Bio at 16.82 subject to Rule 16b-3 | 06/04/2025 |
6 | Q32 Bio Inc. Short Interest Down 26.7 percent in May | 06/18/2025 |
7 | Q32 Bio Appoints Adrien Sipos, M.D., Ph.D., as Interim Chief Medical Officer QTTB Stock News | 06/25/2025 |
8 | Q32 Bio Inc. Stock Analysis and Forecast - Outstanding yields - Jammu Links News | 07/18/2025 |
| Begin Period Cash Flow | 31.3 M | |
| Total Cashflows From Investing Activities | 19.9 M |
Q32 Bio Relative Risk vs. Return Landscape
If you would invest 203.00 in Q32 Bio on April 21, 2025 and sell it today you would earn a total of 16.00 from holding Q32 Bio or generate 7.88% return on investment over 90 days. Q32 Bio is currently generating 1.0443% in daily expected returns and assumes 16.902% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Q32, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Q32 Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Q32 Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Q32 Bio, and traders can use it to determine the average amount a Q32 Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0618
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | QTTB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 16.9 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.04 actual daily | 20 80% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Q32 Bio is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Q32 Bio by adding it to a well-diversified portfolio.
Q32 Bio Fundamentals Growth
Q32 Stock prices reflect investors' perceptions of the future prospects and financial health of Q32 Bio, and Q32 Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Q32 Stock performance.
| Return On Equity | -2.67 | ||||
| Return On Asset | -0.34 | ||||
| Current Valuation | (19.91 M) | ||||
| Shares Outstanding | 12.2 M | ||||
| Price To Book | 3.55 X | ||||
| Gross Profit | (48.25 M) | ||||
| EBITDA | (45.3 M) | ||||
| Net Income | (47.73 M) | ||||
| Total Debt | 18.9 M | ||||
| Book Value Per Share | (0.33) X | ||||
| Cash Flow From Operations | (67.72 M) | ||||
| Earnings Per Share | (7.57) X | ||||
| Market Capitalization | 26.77 M | ||||
| Total Asset | 92.33 M | ||||
| Retained Earnings | (234.81 M) | ||||
| Working Capital | 65.41 M | ||||
About Q32 Bio Performance
By analyzing Q32 Bio's fundamental ratios, stakeholders can gain valuable insights into Q32 Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Q32 Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Q32 Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 221.19 | 232.25 | |
| Return On Tangible Assets | (0.52) | (0.54) | |
| Return On Capital Employed | (0.87) | (0.91) | |
| Return On Assets | (0.52) | (0.54) | |
| Return On Equity | (8.41) | (7.99) |
Things to note about Q32 Bio performance evaluation
Checking the ongoing alerts about Q32 Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Q32 Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Q32 Bio is way too risky over 90 days horizon | |
| Q32 Bio appears to be risky and price may revert if volatility continues | |
| Q32 Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (47.73 M) with loss before overhead, payroll, taxes, and interest of (48.25 M). | |
| Q32 Bio generates negative cash flow from operations | |
| About 73.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Q32 Bio Inc. Stock Analysis and Forecast - Outstanding yields - Jammu Links News |
- Analyzing Q32 Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Q32 Bio's stock is overvalued or undervalued compared to its peers.
- Examining Q32 Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Q32 Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Q32 Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Q32 Bio's stock. These opinions can provide insight into Q32 Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Q32 Stock analysis
When running Q32 Bio's price analysis, check to measure Q32 Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Q32 Bio is operating at the current time. Most of Q32 Bio's value examination focuses on studying past and present price action to predict the probability of Q32 Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Q32 Bio's price. Additionally, you may evaluate how the addition of Q32 Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |